Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CERS
#3124
Cerus Corp
2.0
1
USD
+4.69%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+4.69%
Changement Mensuel
+18.93%
Evolution sur 6 mois
+25.62%
Changement Annuel
+50.00%
Clôture Précédente
1.9
2
Open
2.0
1
Bid
Ask
Low
2.0
1
High
2.0
1
Volume
36
Marchés
Actions des Marchés US
Soins de Santé
CERS
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
168.22 M
173.72 M
177.62 M
181.28 M
185.79 M
192.17 M
—
Valuation ratios
Enterprise value
1.19 B
1.22 B
716.89 M
476.72 M
364.7 M
473.6 M
1.56 B
Price to earnings ratio
-18.95
-21.45
-15.58
-10.29
-14
-25.75
-73.63
Price to sales ratio
9.93
7.31
3.51
2.08
1.41
1.68
-5 266.87
Price to cash flow ratio
-27.85
-34.39
-25.78
-9.02
25.02
81.17
237.88
Price to book ratio
10.93
13.78
9.77
7.4
5.06
6.11
9.82
Enterprise value to EBITDA ratio
-20.42
64.19
14.36
8.96
3.9
4.35
-1.25
Profitability ratios
Return on assets %
-0.27
-0.23
-0.2
-0.19
-0.1
-0.07
-0.07
Return on equity %
-0.58
-0.64
-0.62
-0.7
-0.37
-0.24
-0.27
Return on invested capital %
-500.85
-337.55
-158.07
-123.97
-68.14
-40.64
-50.88
Gross margin %
63.98
100
100
100
100
100
400
Operating margin %
-51.06
-30.68
-18.1
-16.09
-7.07
-3.71
-691.01
EBITDA margin %
-48.34
11.09
23.29
22.76
33.96
37.04
214.31 K
Net margin %
-52.39
-34.09
-22.72
-20.07
-10.39
-6.68
7 840.3
Liquidity ratios
Quick ratio
2.67
2.04
1.21
1.55
1.79
1.17
5.44
Current ratio
3.06
2.38
1.45
2.14
2.39
1.73
7.94
Inventory turnover
1.93
—
—
—
—
—
—
Asset turnover
0.59
0.7
0.83
0.9
1.01
1.11
-0.01
Solvency ratios
Debt to assets ratio
0.3
0.37
0.4
0.49
0.49
0.44
1.84
Debt to equity ratio
0.64
1.04
1.29
1.82
1.75
1.51
6.68
Long term debt to total assets ratio
0.22
0.29
0.32
0.4
0.42
0.38
1.58
Long term debt to total equity ratio
0.46
0.82
1.03
1.52
1.5
1.31
5.75
Per share metrics
Operating cash flow per share
-0.25
-0.2
-0.15
-0.24
0.06
0.03
0.03
EBIT per share
-0.36
0.08
0.23
0.22
0.36
0.45
-0.79
EBITDA per share
-0.34
0.1
0.25
0.24
0.37
0.45
-0.78
Total debt per share
0.41
0.51
0.49
0.53
0.53
0.51
2.07
Cash per share
0.81
0.76
0.58
0.37
0.44
0.43
1.68
Net current asset value per share
1.12
1.09
0.96
0.8
0.82
0.91
3.53
Tangible book value per share
0.64
0.49
0.38
0.28
0.3
0.33
1.22
Working capital per share
0.75
0.63
0.3
0.43
0.48
0.39
1.73
Book value per share
0.63
0.49
0.38
0.29
0.3
0.34
1.24
Cerus Corporation
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.
Nouvelles
Jensen, directrice juridique de Cerus Corp, vend pour 187.000$ d’actions
Jensen, Cerus Corp chief legal officer, sells $187k in stock
Le directeur financier de Cerus Corp vend pour 211.000$ d’actions
Cerus Corp : le directeur médical Benjamin vend pour 168.000$ d’actions
Le COO de Cerus Corp, Jayaraman, vend pour 273.000$ d’actions
Le PDG de Cerus Corp, Greenman, vend pour 742.000$ d’actions
Cerus Corp COO Jayaraman sells $273k in shares
Cerus Corp CEO Greenman sells $742k in shares
Cerus Corp: chief medical officer Benjamin sells $168k in shares
Cerus Corp CFO green sells $211k in shares
Cerus names COO Vivek Jayaraman as next CEO effective July 1
Le directeur financier de Cerus, Kevin Green, vend pour 169.000$ d’actions